Yarlagadda S. Babu, Chief Discovery Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 63,030 shares at $13.88 ($875K) on 2022-11-14, disclosed to the SEC on 2022-11-16.
Open-market sale of $875k BCRX by Chief Discovery Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.88 | 31,515 | $437K | 50.0% |
| 2 | $13.88 | 31,515 | $437K | 50.0% |
| Total | $13.88 avg | 63,030 | $875K | 100% |
| Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |
| BCRX | SELL | 2015-03-20 | $123K | — | Filing → |